Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Open, Classified

Rapid Refill Continuous Injection System, UPN M00566001

FDA Recall Z-2725-2026 · Posted 2026-07-10

Recalling FirmBoston Scientific Corporation
Recall StatusOpen, Classified
Product CodeKYZ
Date Initiated2026-06-30
Product Quantity153,921 (US); 119,274 (OUS)

Reason for Recall

Devices contain recalled Medline Namic Angiographic Control Syringe with Rotating Adaptor. There is a risk of syringe loosening or disconnecting from the manifold, resulting in loose connection or complete disconnection. May lead to difficulty connecting syringe, inability to aspirate or inject properly, fluid leakage, or separation of the syringe from the system, potentially requiring device exchange and prolonging the procedure.

Firm Action

On June 30, 2026, the firm began notifying US customers via letters titled "Urgent Medical Device Removal - Immediate Action Required." Customers were instructed to immediately stop further use or distribution of affected product, and segregate it. Continue to follow the standard care when monitoring patients treated with the contact. Product is to be returned to Boston Scientific.

Root Cause

Under Investigation by firm

Distribution Pattern

US Nationwide distribution. OUS consignee list pending.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑